DOPAMINE HCI
- Product NDC
- 51662-1291
- 11-digit product format
- 516621291
- Labeler code
- 51662
- Product ID
- 51662-1291_1200755c-a6f2-f1b4-e063-6394a90aaf1d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOPAMINE HCI
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- NDA018132
- Marketing category
- NDA
- Marketing start
- 2018-09-19
- Substance
- DOPAMINE HYDROCHLORIDE
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Catecholamine [EPC], Catecholamines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | 51662-1291 | Y | Unknown FDA exclusion code: Y | excluded / ndc_excluded.zip | 110d247fa046… | a55b01930146… | ||
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 51662-1291 | 51662-1291-1 | Y | Unknown FDA exclusion code: Y | excluded / ndc_excluded.zip | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018132-001 | DOPAMINE HYDROCHLORIDE | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N018132-002 | DOPAMINE HYDROCHLORIDE | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 |
| N018132-003 | DOPAMINE HYDROCHLORIDE | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 |
| N018132-004 | DOPAMINE HYDROCHLORIDE | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N018132-001 | AP |
| N018132-002 | AP |
| N018132-003 | AP |
| N018132-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-001 | DOPAMINE HYDROCHLORIDE | 40MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-002 | DOPAMINE HYDROCHLORIDE | 80MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-003 | DOPAMINE HYDROCHLORIDE | 160MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-02-04 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-004 | DOPAMINE HYDROCHLORIDE | 80MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1982-07-09 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N018132-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018132-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018132-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018132-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018132-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018132-004 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018132-004 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018132-004 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018132-004 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018132-004 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018132-004 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-003 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018132-004 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-003 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018132-004 | AP | 1 | d06236e962d9… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOPAMINE HCI
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOPAMINE HYDROCHLORIDE | 40 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7L3E358N9L | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 763d2b07-9cea-782e-e053-2a91aa0adc01 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6aba2aa6-bc33-4b0c-a81c-06f5fb4cc762 | Product name | 2 | 20180613 |
| b2a69ae1-a082-5ec0-42b6-e3c38800f173 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51662-1291-1 | 2020-02-07 | C162847 | 48780-1 | 9d75b9d0-bbd2-f424-e053-dadaa90a57ce | DOPAMINE HCI INJ., USP 200mg (40 mg/mL) 5mL VIAL |
| 51662-1291-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bbd2-f424-e053-dadaa90a57ce | DOPAMINE HCI INJ., USP 200mg (40 mg/mL) 5mL VIAL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1291-1 | DOPAMINE HCI | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 7 | |
| 51662-1291-2 | DOPAMINE HCI | 1 in 1 POUCH | INJECTION, SOLUTION, CONCENTRATE | 1 | 7 | |
| 51662-1291-2 | DOPAMINE HCI | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 5 | 7 | |
| 51662-1291-3 | DOPAMINE HCI | 25 in 1 CASE | INJECTION, SOLUTION, CONCENTRATE | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1291 | DOPAMINE HCI INJECTION, SOLUTION, CONCENTRATE [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 7 | Current NDC, Legacy NDC, 4 package rows | 20240224_763d2b07-9cea-782e-e053-2a91aa0adc01.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOPamine Hydrochloride | DOPAMINE HYDROCHLORIDE | Hospira, Inc. | 1f306ad2-3606-4525-5a8a-ce78f426c1a2 | 2026-05-13 | Warnings, Adverse reactions | 018132 NDA018132 |
| DOPamine Hydrochloride | DOPAMINE HYDROCHLORIDE | ProPharma Distribution | 45b0729e-529b-02f6-e063-6294a90a31d3 | 2025-12-11 | Warnings, Adverse reactions | 018132 NDA018132 |
| Dopamine Hydrochloride | DOPAMINE HYDROCHLORIDE | Henry Schein, Inc. | fc1eb709-ce72-413e-9043-8e463ef0fd36 | 2025-10-30 | Warnings, Adverse reactions | 018132 NDA018132 |
| Dopamine Hydrochloride | DOPAMINE HYDROCHLORIDE | Henry Schein, Inc. | 460906f7-b532-4ddb-a799-ad7b50488143 | 2025-08-05 | Warnings, Adverse reactions | 018132 NDA018132 |
| DOPAMINE HCI | DOPAMINE HCI | HF Acquisition Co. LLC, DBA Health First | 74205252-3949-57fa-e053-2991aa0aee4d | 2024-02-22 | Warnings, Adverse reactions | 018132 NDA018132 |
| DOPAMINE HCI | DOPAMINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 763d2b07-9cea-782e-e053-2a91aa0adc01 | 2024-02-22 | Warnings, Adverse reactions | 018132 NDA018132 51662-1291 |
| DOPamine Hydrochloride | DOPAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | b61fffd0-7bc8-09e2-e053-2995a90ae0e4 | 2023-05-30 | Warnings, Adverse reactions | 018132 NDA018132 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51662-1291-1 | 51662129101 | 5 mL in 1 VIAL, SINGLE-DOSE (51662-1291-1) | 5 ml | 2018-09-19 | 0000-00-00 | No | No | Current |
| 51662-1291-2 | 51662129102 | 1 in 1 POUCH | Historical | |||||
| 51662-1291-3 | 51662129103 | 25 POUCH in 1 CASE (51662-1291-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1291-2) / 5 mL in 1 VIAL, SINGLE-DOSE | 25 pouch | 2022-09-15 | 0000-00-00 | No | No | Current |